Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens

Biomedicine and Pharmacotherapy

Volumn 59, Issue 1-2, 2005, Pages 1-7

  García Pérez, Bartolo ^a   Ayala, Ignacio ^b   Castells, Maria Teresa ^b   Doménech, Guillermo ^b   Sánchez Polo, Maria Teresa ^a   García Partida, Paulino ^c   Valdés, Mariano ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Atherosclerosis; Ca antagonists; Chicken

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DILTIAZEM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIFEDIPINE; TRIACYLGLYCEROL; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; CALCIUM BLOOD LEVEL; CHICKEN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MEGADOSE; MALE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 14644405564     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.06.001     Document Type: Article

References (67)

1. S.L. Blumlein, R. Sievers, P. Kidd, and W.W. Parmley Mechanism of protection from atherosclerosis of verapamil in the cholesterol-fed rabbit Am. J. Cardiol. 55 1985 165 171
2. A.L. Catapano Calcium antagonists and atherosclerosis Eur. Heart J. 18 A 1997 80 86
3. C.T. Chan, H. Wells, and D.M. Kramsch Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels Circ. Res. 43 1978 115 125
4. A. Corsini, R. Fumagalli, and R. Paoletti Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2 Pharmacol. Res. Comm. 18 1986 1 16
5. A. Daugherty, D.L. Rateri, G. Schonfeld, and B.E. Sobel Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: An effect dissociable from calcium entry blockade Br. J. Pharmacol. 91 1987 113 118
6. O.R. Etingin, and D.P. Hajjar Nifedipine increases cholesteryl ester hydrolysis in lipid-laden rabbit arterial smooth muscle cells J. Clin. Invest. 75 1985 1554 1558
7. O.R. Etingin, and D.P. Hajjar Calcium channel blockers enhance cholesterol ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue Circ. Res. 66 1990 185 190
8. H. Farghali, E. Kmonickova, H. Lotkova, and K. Martinek Evaluation of calcium channel blockers as potential hepatoprotective agents in oxidative stress injury of perfused hepatocytes Physiol. Res. 49 2000 261 268
9. A. Fleckenstein, M. Frey, F. Fhimm, and G. Fleckenstein-Grun Excessive mural calcium overload--a predominant causal factor in the development of stenosing coronary plaques in humans Cardiovasc. Drug Ther. 4 1990 1005 1013
10. B. García Ṕrez, J.V. Ortega, J. Fernández-Pardo, and M. Vald́s Efecto antiateroǵnico de la atorvastatina en pollos alimentados con una dieta rica en huevos Clin. Invest. Arterioscl. 782 2002 20 27
11. B. García Ṕrez, I. Ayala, M.T. Castells, J.F. Madrid, M.R. Ortega, and J.V. Ortega Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine, verapamil and diltiazem Histol. Histopathol. 18 2003 1027 1033
12. R. Ginsburg, K. Davis, M.R. Bristow, K. McKennett, S.R. Kodski, and M.E. Billingham Calcium antagonists suppress atherogenesis in aorta but not in the intramural coronary arteries of cholesterol-fed rabbits Lab. Invest. 49 1983 154 162
13. R.G. Gosling, J.A. Haynes, and G. Segre-Mackay Induction of atheroma in cockerels as a model for studying alterations in blood flow J. Atheroscl. Res. 9 1969 47 51
14. G.A. Gresham Animal models of atherosclerosis An integrated view on atherosclerosis 1983 Plenum Press New York p. 87
15. J.B. Habib, C. Bosaller, S. Weells, C. Williams, J.D. Morrissett, and P.D. Henry Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbits treated with the calcium blocker PN-200 Circul. Res. 58 1986 305 309
16. A. Hamsten Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease Baillier Clin. Endoc. 4 1990 895 922
17. B. Hennig, P. Meerarani, P. Ramadass, M. Toborek, A. Malecki, and R. Slim Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis Nutrition 15 1999 744 748
18. B. Hennig, M. Toborek, and C.J. Mcclain Antiatherogenic properties of zinc: implications in endothelial cell metabolism Nutrition 12 1996 711 717
19. P.D. Henry Mechanism of action of calcium antagonists in cardiac and smooth muscle P.H. Stone E.M. Antman Calcium channel blocking agents in the treatment of cardiovascular disorders 1983 Futura New York p. 107
20. P.D. Henry, and K.I. Bentley Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine J. Clin. Invest. 68 1981 1366 1369
21. I.K. Inouye, B.M. Massie, and N. Benowitz Antihypertensive therapy with diltiazem and comparison with hydroclorothiazide Am. J. Cardiol. 53 1984 1588 1596
22. M. Kates Techniques of lipidology E.T. Works Laboratory techniques in biochemistry and molecular biology 1972 North Holland Publishing Company Amsterdam 347 353
23. H. Kesteloot, S. Sans, and D. Kromhout Evolution of all-causes and cardiovascular mortality in the age-group 75-84:years in Europe during the period 1970-1996 Eur. Heart J. 23 2002 384 398
24. A. Kjell, and M.D. Midtbo Effects on long-term verapamil therapy on serum lipids and other metabolic parameters Am. J. Cardiol. 66 1990 131 151
25. G.M. Kostner, E. Molinari, and P. Pichler Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol Clin. Chem. Acta. 148 1985 139 147
26. D.M. Kramsch, A.J. Aspen, and C.S. Apstein Suppresion of experimental atherosclerosis by the Ca++ antagonist Lanthanum J. Clin. Invest. 65 1980 967 981
27. D. Kritchevsky, S.A. Tepper, and D.M. Klurfeld Flordipine, a calcium channel blocker which does not influence lipidemia or atherosclerosis in cholesterol-fed rabbits Atherosclerosis 69 1988 89 92
28. L.R. Krussell, L.T. Jespersen, A. Schimnitz, K. Thomsen, and O.L. Pedersen Repetitive natriuresis and blood pressure long-term calcium entry blockade with israldipine Hypertension 10 1981 577 581
29. C.K. Lardinois, and S.L. Neuman The effects of antihypertensive agents on serum lipids and lipoproteins Arch. Intern. Med. 148 1988 1280 1288
30. A. Lehtonen, and A. Gordin Metabolic parameters after changing from hyroclorothiazide to verapamil treatment in hypertension Eur. J. Clin. Pharmacol. 27 1984 153 157
31. R. Loutzenhiser, and M. Epstein Effects of calcium antagonists on renal hemodynamics Am. J. Physiol. 249 1985 619 629
32. R.P. Mason Mechanisms of atherosclerosis plaque stabilization for a lipophilic calcium antagonist amlodipine Am. J. Cardiol. 88 2001 2M 6M
33. A.B. Miller Effect of lipid-lowering agents, angiotensin-converting enzyme inhibitors, and calcium antagonists on coronary disease risk Am. J. Cardiol. 88 2001 21M 25M
34. K. Mitbo, O. Hals, and J. Van der Meer Verapamil compared with nifedipine in treatment of essential hypertension J. Cardiovasc. Pharmacol. 4 1982 S363 S368
35. M. Motro, J. Shemesh, and E. Grossman Coronary benefits of calcium antagonist therapy for patients with hypertension Curr. Opin. Cardiol. 16 2001 349 355
36. M. Narayanaswamy, K.C. Wright, and K. Kandarpa Animal models for atherosclerosis, restenosis and endovascular graft research J. Vasc. Interv. Radiol. 11 2000 6 17
37. I. Ohata, N. Sakamoto, K. Nagano, and H. Maeno Low density lipoprotein lowering and high density lipoprotein elevating effects of nicardipine in rats Biochem. Pharmacol. 33 1984 2199 2205
38. A.N. Orekhov, E.R. Andreevan, A.V. Krushinsky, and V.N. Smirnov Primary cultures of enzyme-isolated cells from normal and atherosclerotic human aorta Med. Biol. 62 1984 255 259
39. A.N. Orekhov, V.V. Tertov, I.D. Novikov, A.V. Krushinsky, E.R. Aandreeva, and V.Z. Lankin Lipids in cells of atherosclerotic and univolved human aorta. Part 1. Lipid composition of aortic tissue and enzyme isolated and cultured cells Exp. Mol. Pathol. 42 1985 117 137
40. A.N. Orekhov, V.V. Tertov, S.A. Kudryashov, K.A. Khasimov, and V.N. Smirnov Primary culture of human aortic intima cells as a model for testing atherosclerotic drugs Atherosclerosis 60 1986 101 110
41. A.N. Orekhov, V.V. Tertov, and K.A. Khasimov Evidence of antiatherosclerotic action of verapamil from direct effect on arterial cell Am. J. Cardiol. 59 1987 495 496
42. S. Pangiotopoulos, and W.G. Nayler Calcium antagonists and suppression of atherosclerosis J. Mol. Cell. Cardiol. 16 1984 108 112
43. R. Paoletti, F. Bernini, R. Fumagalli, and A. Corsini Calcium antagonists and LDL receptors Ann. N. Y. Acad. Sci. 522 1988 390 398
44. A. Peeters, A.A. Mamun, F. Willekens, and L. Bonneux A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort Eur. Heart J. 23 2002 458 466
45. C.J. Pepine, and E.M. Handberg The vascular biology of hypertension and atherosclerosis and intervention with calcium antagonists and angiotensin-converting enzyme inhibitors Clin. Cardiol. 24 2001 1 5
46. S. Ripa, and R. Ripa Zinc and atherosclerosis Minerva Med. 85 1994 647 654
47. J.C. Romero, L. Raij, J.P. Granjer, L.M. Ruilope, and J.L. Rodicio Multiple effects of calcium entry blocker on renal function in hypertension Hypertension 10 1987 140 151
48. J.C. Romero, L.M. Ruilope, M.D. Bentley, O. Fiksen-Olsen, V. Lahera, and M.J. Vidal Comparison of the effects of calcium antagonists and converting enzyme inhibitor on renal function under normal and hypertensive conditions Am. J. Cardiol. 62 1988 59 68
49. J.L. Rouleau, W.W. Parmley, J. Stevens, J. Wikman-Coffelt, R. Sievers, and R.W. Mahley Verapamil suppresses atherosclerosis in cholesterol-fed rabbits J. Am. Coll. Cardiol. 6 1983 453 460
50. L.M. Ruilope, B. Miranda, A. Oliet, J.M. Alcazar, J. Bigorra, and J.L. Rodicio Persistence of the natriuretic effect of calcium entry blockers J. Cardiovasc. Pharmacol. 12 1988 136 139
51. S. Sans, H. Kesteloot, and D. Kromhout The burden of cardiovascular disease mortality in Europe Eur. Heart J. 18 1997 1231 1248
52. W.G. Siller The pathology of experimental atherosclerosis in egg-fed fowls J. Atheroscl. Res. 1 1961 189 204
53. H.E. Sluiter, F.T. Huysmans, T.A. Thien, H.J. Van Lier, and R.A. Koene Haemodynamic, hormonal and diuretic effects of felodipine in healthy normotensive volunteers Drugs 29 1985 26 35
54. G. Sobala, E.J. Menzel, and H. Sinzinger Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation Biochem. Pharmacol. 61 2001 373 379
55. O. Stein, E. Leitersdorf, and Y. Stein Verapamil enhances receptor-mediated endocytosis of LDL by aortic cells in culture Arteriosclerosis 5 1985 35 44
56. O. Stein, and Y. Stein Effects of verapamil on cholesteryl ester hydrolysis and reesterification in macrophages Arteriosclerosis 7 1987 578 584
57. M. Sugano, Y. Nakashima, T. Matushima, K. Takahara, M. Takasugi, and A. Kuroiwa Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection Arteriosclerosis 6 1986 237 241
58. M. Sugano, Y. Nakashima, H. Tasaki, M. Takasugi, A. Kuroiwa, and O. Koide Effects of diltiazem on suppression and regression of experimental atherosclerosis Br. J. Exp. Pathol. 69 1988 515 523
59. G.D. Tilton, L.M. Buja, D.W. Bilheimer, J. Asthon, J. McNatt, and T. Kita Failure of slow channel calcium antagonist verapamil to retard ahterosclerosis in the WHHL rabbit, an animal model of familiar hypercholesterolemia J. Am. Coll. Cardiol. 6 1985 141 144
60. M. Vald́s Estudio anatomopatológico de las aortas del grupo de pollos alimentado con huevos (arteriosclerosos) y su comparación con los normales Rev. Esp. Cardiol. 29 1976 377 384
61. J.L.M. Van Nieker, T. Hendriks, H.H.M. Deboer, and A. Van Laar Does nifedipine suppress atherogenesis in WHHL rabbits? Atherosclerosis 53 1984 91 98
62. B. Vessby, J. Abelin, and M. Finnson Effects of nifedipine treatment on carbohydrate and lipoprotein metabolism Curr Ther Res 33 1983 1075 1081
63. D. Vesselinovitch, J.F. Mullan, R.W. Wissler, H.R. Davis, and T. Bridenstine Carotid atherogenesis inhibited by simpathectomy, propanolol and nifedipine in rhesus monkey Arteriosclerosis 6 1986 561 570
64. J. Wang Effects of diltiazem on plasma Zn, copper in coronary heart patients Zhonghua. Xin Xue Guan Bing Za Zhi 19 1991 24 26
65. R. Wang, M. Xu, R. Marcel, G. Bouliane, and D.Z. Fisher Selective neo-intimal gene transfer in an avian model of vascular injury Atherosclerosis 146 1999 71 82
66. A.L. Willis, B. Nagel, V. Churchill, M.A. Whyte, D.L. Smith, and I. Mahmud Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits Arteriosclerosis 5 1985 250 255
67. H.Y. Wong The cockerel as an animal model for atherosclerosis research Adv. Exp. Med. Biol. 63 1975 381 391